Navigation Links
SARS: India's drugs in demand,,

In a report from the Indian capital, the SARS virus has increased demand for macrolides, resulting in severely affected countries like China approaching the Indian pharmaceutical companies for additional supplies. Macrolides are a family of antibiotics that treat a wide range of bacterial infections. While doctors are still battling with the exact cure for SARS, macrolides, commonly used for treating lower respiratory tract infections, seems to have emerged as a preferred drug// in treating SARS.

Indian pharmaceutical companies have reported that order inquiries have gone up by four to five times from China and Southeast Asia, which forms the epicenter of the epidemic. China is turning to India at this stage as it traditionally meets some of its macrolide requirements.

While medical practitioners are still struggling to find the cure for the killer disease, the macrolides, widely used for treating pneumonia, are the favored drug prescribed by medical pfsractitioners at present. Macrolides include drugs such as erythromycin, azithromycin, clarithromycin and roxithromycin. They are particularly useful in the treatment of lower respiratory track infections.
'"/>




Page: 1

Related medicine news :

1. Indias anti-AIDS drug market engaged in price war
2. Indias Hospitals Among The Best, Says Renuka Chowdhury
3. Indias vaccination project gets a boost
4. WHO Commends Indias Bird Flu Response
5. Minister Of State For Industry Urges Corporate Sectors To Help Indias Disabled Population
6. Indias Economic Boom Pack To Waste Children Life
7. Indias Northeast Students to Get Satellite-based Education Soon
8. Norway Grants $80 mn to Indias Health Mission
9. Pakistani Child is Indias Youngest Liver Transplant Recipient
10. Avian flu-free Status to Boost Indias Poultry Exports
11. Britains Support for Indias Health Programme
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... ... April 25, 2017 , ... As President Trump challenges the ... how his administration could impact the employee benefits industry. James Slotnick, AVP, Government ... likely to make it through Congress. His discussion will focus on the current ...
(Date:4/25/2017)... ... April 25, 2017 , ... Patients who ... achieves results in a fraction of the time as traditional braces – Wilckodontics®. ... Dental Specialists, now offers this revolutionary treatment with or without a referral. ...
(Date:4/25/2017)... Minneapolis MN (PRWEB) , ... April 25, 2017 , ... ... patients and recreational users to dispensaries and head shops –can’t help but be heartened ... loathing for the tell-tale cannabis odor aptly described as “skunk smell.” At last ...
(Date:4/25/2017)... Hollywood, Fl (PRWEB) , ... April 25, 2017 , ... ... than Memorial Regional Hospital, according to a special report in the May issue of ... Hospital its highest quality ranking for results achieved during and after coronary bypass ...
(Date:4/24/2017)... ... April 24, 2017 , ... LG CNS ... Own Device (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s national conference. ... pairs medical devices with a pre-programmed tablet in a remarkably easy-to-use kit for ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, Inc. ... clinical-stage biopharmaceutical company developing new treatments for cancer ... closing of its previously announced underwritten public offering ... a public offering price of $2.00 per share, ... offering expenses payable by Sorrento.  The net proceeds ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
Breaking Medicine Technology: